Serviço de Anestesiologia, ULSM (Unidade Local de Saúde de Matosinhos), Matosinhos, Portugal.
ULSM (Unidade Local de Saúde de Matosinhos), Unidade de Medicina Hiperbárica, Matosinhos, Portugal.
Clin Transl Oncol. 2022 Dec;24(12):2466-2474. doi: 10.1007/s12094-022-02892-x. Epub 2022 Aug 17.
Cancer remains one of the leading causes of death worldwide, with 50-60% of patients requiring radiotherapy during the course of treatment. Patients' survival rate has increased significantly, with an inevitable increase in the number of patients experiencing side effects from cancer therapy. One such effect is late radiation injuries in which hyperbaric oxygen therapy appears as complementary treatment. With this work we intend to divulge the results of applying hyperbaric oxygen therapy among patients presenting radiation lesions in our Hyperbaric Medicine Unit.
Retrospective analysis of clinical records of patients with radiation lesions treated at the Hyperbaric Medicine Unit assessed by the scale Late Effects of Normal Tissues-Subjective, Objective, Management, Analytical (LENT-SOMA) before and after treatment, between October 2014 and September 2019 were included. Demographic characteristics, primary tumor site, subjective assessment of the LENT-SOMA scale before and after treatment were collected and a comparative analysis (Students t test) was done.
88 patients included: 33 with radiation cystitis, 20 with radiation proctitis, 13 with osteoradionecrosis of the mandible and 22 with radiation enteritis. In all groups, there was a significant decrease (p < 0.005) in the subjective parameter of the LENT-SOMA scale.
Late radiation lesions have a major influence on patients' quality of life. In our study hyperbaric oxygen therapy presents as an effective therapy after the failure of conventional treatments.
Hyperbaric oxygen therapy is an effective complementary therapy in the treatment of refractory radiation lesions.
癌症仍然是全球主要死因之一,50-60%的患者在治疗过程中需要接受放疗。随着患者生存率的显著提高,癌症治疗相关副作用的患者数量也不可避免地增加。其中一种副作用是晚期放射性损伤,高压氧治疗似乎是一种补充治疗方法。通过这项工作,我们旨在揭示高压氧治疗在我们高压医学科接受放射性损伤的患者中的应用结果。
对 2014 年 10 月至 2019 年 9 月在高压医学科接受治疗的放射性损伤患者的临床记录进行回顾性分析,这些患者通过 LENT-SOMA 量表(晚期正常组织效应的主观、客观、管理和分析量表)进行评估,比较治疗前后的评分。收集患者的人口统计学特征、原发肿瘤部位、治疗前后 LENT-SOMA 量表的主观评估,并进行对比分析(学生 t 检验)。
共纳入 88 例患者:33 例放射性膀胱炎,20 例放射性直肠炎,13 例下颌骨放射性骨坏死,22 例放射性肠炎。在所有组中,LENT-SOMA 量表的主观参数均显著下降(p<0.005)。
晚期放射性损伤对患者的生活质量有重大影响。在我们的研究中,高压氧治疗在常规治疗失败后是一种有效的治疗方法。
高压氧治疗是治疗难治性放射性损伤的有效补充治疗方法。